Donald R. Griffin is a prominent inventor based in Los Angeles, CA. He has made significant contributions to the field of hydrogel materials, particularly in modulating immune responses. With a total of 5 patents, Griffin's work is at the forefront of innovative biomedical applications.

Latest Patents

Griffin's latest patents include groundbreaking technologies such as "Microporous Annealed Particle Gels and Methods of Use." This patent describes a hydrogel material designed to modulate immune responses in humans and other mammals. The invention features a collection of microgel particles that, when exposed to an annealing agent, link together to form a covalently-stabilized scaffold. This scaffold has interstitial spaces that can incorporate antigens and adjuvants, enhancing its effectiveness.

Another notable patent is the "Microporous Annealed Particle Gel System." This invention also utilizes microgel particles that form a covalently-stabilized scaffold with pores, which are devoid of hydrogel. This unique structure allows for improved functionality in biomedical applications.

Career Highlights

Donald R. Griffin is affiliated with the University of California, where he continues to advance research in hydrogel technologies. His work has garnered attention for its potential applications in immunology and other medical fields.

Collaborations

Griffin has collaborated with notable colleagues such as Tatiana Segura and Philip Scumpia, contributing to a dynamic research environment that fosters innovation.

Conclusion

Donald R. Griffin's contributions to hydrogel technology and immune modulation exemplify the impact of innovative thinking in the biomedical field. His patents reflect a commitment to advancing science and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.